Cargando…

Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445)

2-(4-aminophenyl)benzothiazole (CJM 126) elicits potent growth inhibition in human-derived breast carcinoma cell lines, including oestrogen receptor-positive (ER+) MCF-7(wt)cells. Analogues substituted in the 3′ position with I (DF 129), CH (3)(DF 203), or CI (DF 229) possess an extended profile of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradshaw, T D, Chua, M-S, Orr, S, Matthews, C S, Stevens, M F G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363474/ https://www.ncbi.nlm.nih.gov/pubmed/10901382 http://dx.doi.org/10.1054/bjoc.2000.1231

Ejemplares similares

2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.
por: Bradshaw, T. D., et al.
Publicado: (1998)

Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo.
por: Bradshaw, T. D., et al.
Publicado: (1998)

Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo
por: Leong, C-O, et al.
Publicado: (2003)

2-(4-Aminophenyl)-1,3-benzothiazole
por: Zhang, Yong, et al.
Publicado: (2008)

Inhibition of tumor growth and angiogenesis by 2-(4-aminophenyl) benzothiazole in orthotopicglioma C6 rat model
por: Lei, De-Qiang, et al.
Publicado: (2018)

In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles
por: Bradshaw, T D, et al.
Publicado: (2002)

First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
por: Kaul, M., et al.
Publicado: (2021)

Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study
por: Mukherjee, A, et al.
Publicado: (2005)

Catalyst-free reductive cyclization of bis(2-aminophenyl) disulfide with CO(2) in the presence of BH(3)NH(3) to synthesize 2-unsubstituted benzothiazole derivatives
por: Li, Xiao, et al.
Publicado: (2022)

(2-Aminophenyl)methanol
por: Zipp, Caitlin F., et al.
Publicado: (2011)

Development of novel apoferritin formulations for antitumour benzothiazoles
por: Breen, Alastair F., et al.
Publicado: (2019)

(3-Aminophenyl)methanol
por: Betz, Richard, et al.
Publicado: (2011)

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014)

NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in mice
por: Zhang, Ruolin, et al.
Publicado: (2023)

3-Aminophenyl naphthalene-1-sulfonate
por: Vennila, Jasmine P., et al.
Publicado: (2008)

4-Aminophenyl naphthalene-1-sulfonate
por: Vennila, Jasmine P., et al.
Publicado: (2008)

Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival
por: Matta, Rita, et al.
Publicado: (2021)

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
por: Boven, E., et al.
Publicado: (1990)

NSC800 microprocessor family handbook.
Publicado: (1981)

N-(2-Aminophenyl)-2-anilinobenzamide
por: Huang, Kun, et al.
Publicado: (2009)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

Letter to the Member of the NSC and others concerned on the fusion of the NSC with Emulsion Experiments Committee into the new Physics III Committee
por: Ericson, T
Publicado: (1966)

A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families
por: Goldstein, A M, et al.
Publicado: (2001)

ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC
por: Stockwin, Luke H, et al.
Publicado: (2009)

Synthesis and Pharmacological Evaluation of Schiff Bases of 4-(2-Aminophenyl)-Morpholines
por: Panneerselvam, P., et al.
Publicado: (2009)

Identification of genes differentially expressed in association with acquired cisplatin resistance
por: Johnsson, A, et al.
Publicado: (2000)

(E)-1-(4-Aminophenyl)ethanone oxime
por: Rafiq, Muhammad, et al.
Publicado: (2008)

(1-Adamantyl)(3-aminophenyl)methanone
por: Rouchal, Michal, et al.
Publicado: (2011)

N-(4-Aminophenyl)-4-methylbenzenesulfonamide
por: Rehman, Jeveria, et al.
Publicado: (2011)

2-(4-Aminophenyl)-1,3-benzoxazole
por: Qu, Yuan, et al.
Publicado: (2008)

(1-Adamantyl)(4-aminophenyl)methanol
por: Rouchal, Michal, et al.
Publicado: (2009)

Bis(3-aminophenyl) sulfone acetonitrile solvate
por: Yao, Wei, et al.
Publicado: (2008)

(2-Aminophenyl)(p-tolyl)methanone
por: Zhang, Dun-Lin, et al.
Publicado: (2010)

Agenda for the meeting of the NSC on 11 January 1965
por: Ericson, T
Publicado: (1965)

Agenda for the NSC meeting on 12 February 1965
por: Ericson, T
Publicado: (1965)

Agenda for the NSC meeting on 12 March 1965
por: Ericson, T
Publicado: (1965)

Agenda for the NSC meeting on 15 November 1965
por: CERN. Geneva. Nuclear Structure Committee
Publicado: (1965)

Agenda for the NSC meeting on 13 June 1966
por: Ericson, T
Publicado: (1965)

Third Conference on nonlinear science and complexity (NSC)
por: Luo, Albert, et al.
Publicado: (2012)

Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance
por: Lage, H, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_kk6p9p40tp40dfmpmmkjv6jd20